Basic and Diluted Net Loss per Share

6 Months Ended

Jul. 31, 2023

The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2023 and 2022:


	Three Months Ended July 31,				Six Months Ended July 31,
	2023		2022		2023		2022
	(in thousands, except share and per share data)
Numerator:
Net loss	$	(125,255)	$	(92,700)	$	(204,643)	$	(181,966)








Denominator:
Weighted average common shares outstanding	355,893,921		336,911,941		353,031,968		335,845,756
Less: Weighted average unvested restricted shares and shares subject to repurchase	(17,114)		(98,386)		(23,495)		(108,984)
Weighted average shares outstanding - Basic and Diluted	355,876,807		336,813,555		353,008,473		335,736,772




Net loss per share - Basic and Diluted	$	(0.35)	$	(0.28)	$	(0.58)	$	(0.54)

The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows:


	July 31, 2023	July 31, 2022
2027 Convertible Notes (on an as-converted basis)	12,483,569	12,483,569
Options to purchase common stock	15,366,376	19,280,776
Restricted stock units	22,763,199	13,377,719
Unvested early exercised common stock options	12,178	89,877
Common stock warrants	34,499,436	35,524,021
Employee stock purchase plan	2,739,885	1,739,928
Total potentially dilutive common share equivalents	87,864,643	82,495,890

PRSUs granted were excluded from the above table because the respective stock price targets have not been met as of July 31, 2023.